Search results for "Opium"

showing 10 items of 168 documents

Tiotropium add-on therapy reduces seasonal peaks of asthma worsening in adults with symptomatic severe asthma

2019

Despite the use of preferred controller therapies (including inhaled corticosteroids [ICS] with or without additional long-acting β2-agonists [LABAs]), a large proportion of patients with asthma have poor disease control, leaving them at risk of recurring symptoms and episodes of asthma exacerbations and worsening [1, 2]. Such problems can be triggered by many different environmental factors including pollutants, respiratory infections or allergens [3]. They may occur sporadically, but are often determined by seasons, mirroring seasonal patterns of allergen exposure and prevalence of respiratory viral infection [3, 4]. They can cause reduced quality of life, increase asthma burden [2, 3], a…

AdultPulmonary and Respiratory Medicinemedicine.medical_specialtySevere asthma03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Administration InhalationmedicineHumans030212 general & internal medicineTiotropium BromideAsthmaWork productivitybusiness.industryConflict of interestmedicine.diseaseAsthmaBronchodilator AgentsAdd on therapy030228 respiratory systemFamily medicineAbsenteeismDrug Therapy CombinationSeasonsALLERGEN EXPOSUREbusinessEuropean Respiratory Journal
researchProduct

β2 long-acting and anticholinergic drugs control TGF-β1-mediated neutrophilic inflammation in COPD

2012

AbstractWe quantified TGF-β1 and acetylcholine (ACh) concentrations in induced sputum supernatants (ISSs) from 18 healthy controls (HC), 22 healthy smokers (HS) and 21 COPDs. ISSs from HC, HS and COPD as well as rhTGF-β1 were also tested in neutrophil adhesion and in mAChR2, mAChR3 and ChAT expression experiments in human bronchial epithelial cells (16-HBE). Finally, we evaluated the effects of Olodaterol (a novel inhaled β2-adrenoceptor agonist) and Tiotropium Spiriva®, alone or in combination, on neutrophil adhesion and mAChRs and ChAT expression in stimulated 16-HBE. The results showed that 1) TGF-β1 and ACh concentrations are increased in ISSs from COPD in comparison to HC and HS, and T…

Agonistmedicine.medical_specialtymedicine.drug_classchemistry.chemical_compoundInternal medicineTGF-β1Anticholinergic drugMuscarinic acetylcholine receptormedicineCOPDReceptorMolecular BiologyBeta2 long actingCOPDChemistryOlodaterolTiotropium bromidemedicine.diseaserespiratory tract diseasesEndocrinologyMolecular MedicineNeutrophilic inflammationBronchoconstrictionmedicine.symptomAcetylcholinemedicine.drugBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
researchProduct

Homoleptic heavy alkaline Earth and europium triazenides.

2009

The sigma-bond metathesis reaction between PhSiH(3) and the heteroleptic metal pentafluorophenyl compounds [Dmp(Tph)N(3)MC(6)F(5)(thf)(n)] (Dmp = 2,6-Mes(2)C(6)H(3) with Mes = 2,4,6-Me(3)C(6)H(2); Tph = 2-TripC(6)H(4) with Trip = 2,4,6-(i)Pr(3)C(6)H(2); n = 1, 2; M = Sr, Ba, Eu) supported by sterically crowded, biphenyl- and terphenyl-substituented triazenido ligands afforded the first homoleptic stontium, barium, and europium triazenides [M{N(3)Dmp(Tph)}(2)] {M = Sr (2), Ba (4), Eu (5)}. Crystallization of 2 from an n-heptane/1,2-dimethoxyethane mixture gave the complex [Sr{N(3)Dmp(Tph)}(2)(dme)] (3). All new compounds have been characterized by (1)H and (13)C NMR spectroscopy (not 5), ele…

Alkaline earth metalDenticityCoordination sphereInorganic chemistrychemistry.chemical_elementInfrared spectroscopyMedicinal chemistryInorganic Chemistrychemistry.chemical_compoundchemistryTerphenylHapticityPhysical and Theoretical ChemistryHomolepticEuropiumInorganic chemistry
researchProduct

The anti-inflammatory properties of tiotropium

2018

BenzoxazinePulmonary and Respiratory Medicinemedicine.drug_classbusiness.industryScopolamine DerivativesPulmonary diseaseTiotropium bromidePharmacologySettore MED/10 - Malattie Dell'Apparato RespiratorioAnti-inflammatory03 medical and health sciencesAnti-Inflammatory AgentPulmonary Disease Chronic ObstructiveScopolamine Derivative0302 clinical medicine030228 respiratory systemDouble-Blind Methodmedicine030212 general & internal medicineTiotropium Bromidebusinessmedicine.drugHuman
researchProduct

Chromo-fluorogenic BODIPY-complexes for selective detection of V-type nerve agent surrogates

2014

Two new Eu3+ and Au3+ BODIPY-complexes capable of chromofluorogenically detecting micromolar concentrations of V-type nerve agent surrogates by a simple displacement assay are described

Boron CompoundsSURFACECHEMICAL WARFARE AGENTSCatalysischemistry.chemical_compoundQUIMICA ORGANICAEuropiumMIMICSOrganometallic CompoundsMaterials ChemistrymedicineSENSORSNerve agentMolecular StructureQUIMICA INORGANICAMetals and AlloysOrganothiophosphorus CompoundsGeneral ChemistryCombinatorial chemistrySurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialschemistryCeramics and CompositesGoldBODIPYGOLD(III) COMPLEXESDYESmedicine.drug
researchProduct

IL-17A induces chromatin remodeling promoting IL-8 release in bronchial epithelial cells: Effect of Tiotropium

2016

Abstract Aims IL-17A plays a key role in the persistence of airway inflammation, oxidative stress, and reduction of steroid-sensitivity in COPD. We studied the effect of IL-17A on chromatin remodeling and IL-8 production. Main methods We measured the levels of IL-8 and IL-17A in induced sputum supernatants (ISS) from healthy controls (HCs), healthy smokers (HSs), and COPD patients by enzyme-linked immunosorbent assay (ELISA). A human bronchial epithelial cell line (16HBE) was stimulated with ISS from HCs, HSs, or COPD subjects. IL-8 was evaluated in 16HBE by Western blot and real-time polymerase chain reaction (PCR). Histone deacetylase 2 (HDAC2), acetyl histone H3 (Ac-His H3) (k9) and inhi…

Bronchial epithelial cell0301 basic medicineHistone Deacetylase 2BronchiBiologyGeneral Biochemistry Genetics and Molecular BiologyChromatin remodelingProinflammatory cytokineHistonesChromatin remodelingAndrologyPulmonary Disease Chronic Obstructive03 medical and health sciencesHistone H3Western blotIL-17AmedicineHumansInterleukin 8Tiotropium BromideGeneral Pharmacology Toxicology and PharmaceuticsCells CulturedCOPDBiochemistry Genetics and Molecular Biology (all)IL-8medicine.diagnostic_testHistone deacetylase 2Chronic obstructive pulmonary diseaseAnti-Inflammatory Agents Non-SteroidalInterleukin-17Interleukin-8SmokingSputumEpithelial CellsGeneral MedicineChromatin Assembly and Disassemblymedicine.diseaserespiratory tract diseases030104 developmental biologyPharmacology Toxicology and Pharmaceutics (all)ImmunologyInterleukin 17human activitiesLife Sciences
researchProduct

Inhalation solutions: which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers.

2006

AbstractTherapy of chronic respiratory diseases often involves inhalation therapy with nebulizers. Patients often attempt to shorten the time consuming administration procedure by mixing drug solutions/suspensions for simultaneous inhalation. This article considers the issue of physico-chemical compatibility of admixtures of drug solutions/suspensions in nebulizers.A search of databases, prescribing information and primary literature was conducted to locate literature concerning the physico-chemical compatibility of inhalation solutions/suspensions. This was supplemented by telephone interviews.Admixtures of albuterol with ipratropium and/or cromolyn, of albuterol and budesonide, or tobramy…

BudesonideDrugPulmonary and Respiratory MedicineRespiratory TherapyCystic Fibrosismedia_common.quotation_subjectReviewCompatibilityBenzalkonium chlorideAdministration InhalationCromolyn SodiummedicineDeoxyribonuclease IHumansAlbuterolPediatrics Perinatology and Child HealthAnti-Asthmatic AgentsBudesonideFenoterolmedia_commonExpectorantsInhalationbusiness.industryColistinIpratropiumNebulizers and VaporizersNebulizerAsthmaAcetylcysteineAnti-Bacterial AgentsBronchodilator AgentsNebulizerInhalation solutionsAnesthesiaPediatrics Perinatology and Child HealthIpratropiumColistinTobramycinDrug Therapy Combinationbusinessmedicine.drugJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
researchProduct

In vitro dose comparison of Respimat<sup>®</sup> inhaler with dry powder inhalers for COPD maintenance therapy

2017

Background Combining in vitro mouth-throat deposition measurements, cascade impactor data and computational fluid dynamics (CFD) simulations, four different inhalers were compared which are indicated for chronic obstructive pulmonary disease (COPD) treatment. Methods The Respimat inhaler, the Breezhaler, the Genuair, and the Ellipta were coupled to the idealized Alberta throat model. The modeled dose to the lung (mDTL) was collected downstream of the Alberta throat model using either a filter or a next generation impactor (NGI). Idealized breathing patterns from COPD patient groups - moderate and very severe COPD - were applied. Theoretical lung deposition patterns were assessed by an indiv…

COPDRespimatInhalationbusiness.industryInhalerGeneral MedicineTiotropium bromidemedicine.disease03 medical and health scienceschemistry.chemical_compound0302 clinical medicinemedicine.anatomical_structure030228 respiratory systemchemistryAnesthesiaThroatmedicine030212 general & internal medicineVilanterolbusinessFluticasonemedicine.drugInternational Journal of Chronic Obstructive Pulmonary Disease
researchProduct

Oxygen influence on luminescence properties of rare-earth doped NaLaF 4

2016

Abstract Luminescence properties of erbium and europium doped NaLaF4 with different oxygen content have been studied. Vacuum ultraviolet (VUV) excitation luminescence spectroscopy technique has been applied by using synchrotron radiation excitation. It was found that oxygen impurity leads to significant degradation of Er3+ or Eu3+ emission under VUV excitation. The intensive O2−–Er3+ charge transfer excitation band has been detected from oxygen abundant NaLaF4 in the 150–165 nm spectral range. This band reveals a competing absorption mechanism in oxygen containing NaLaF4. It is clearly demonstrated that one reason for the Er3+ emission degradation in oxygen abundant NaLaF4 is strong suppres…

ChemistryDopingBiophysicsAnalytical chemistrychemistry.chemical_element02 engineering and technologyGeneral Chemistry021001 nanoscience & nanotechnologyCondensed Matter PhysicsPhotochemistry01 natural sciencesBiochemistryOxygenAtomic and Molecular Physics and OpticsIonAbsorption band0103 physical sciences010306 general physics0210 nano-technologySpectroscopyLuminescenceEuropiumExcitationJournal of Luminescence
researchProduct

Efficacy of Tiotropium/Olodaterol Compared with Tiotropium in Patients Naïve to LAMA, LABA and ICS: Pooled Analysis of Four Clinical Trials

2019

Clinical trialmedicine.medical_specialtyPooled analysisbiologybusiness.industryInternal medicineTiotropium-olodaterolMedicineIn patientLamabusinessbiology.organism_classificationD101. CLINICAL AND TRANSLATIONAL STUDIES IN ASTHMA AND COPD
researchProduct